Vaxcyte, Inc.
PCVX · NASDAQ · USD
$71.38
+6.36 9.79%todayNot financial advice.
- Open
- 64.78
- Day range
- 64.78 - 72.44
- 52-week range
- 39.87 - 90.75
- Volume
- 4.38M
- Market cap
- 10.62B
- P/E ratio
- —
- EPS
- -7.71
- Dividend yield
- 0.00%
- Beta
- 0.85
Performance
W
+25.76%
1M
+18.99%
3M
+19.22%
6M
+16.81%
YTD
+55.75%
Y
+75.17%
5Y
+187.59%
All
+243.17%
In the news
Oct 9
Vaxcyte Raises $1.10 Billion Through Concurrent Stock and Convertible Debt Offerings
Vaxcyte, Inc. raised over $1.1 billion through concurrent equity and debt offerings to strengthen its balance sheet and fund pipeline development.
Company news
Oct 9
Vaxcyte Closes $1.15 Billion Equity and Convertible Debt Offerings
Vaxcyte, Inc. has finalized concurrent stock and convertible debt offerings of $1.15 billion to fund its Phase 3 VAX-31 vaccine program.
Company news
Oct 9
Vaxcyte Closes $1.15 Billion Offerings of Stock and Convertible Notes
Vaxcyte, Inc. raised $1.15 billion to fund clinical development, manufacturing scale-up, and commercial prep for its pneumococcal vaccine candidate.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-PCVX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Vaxcyte, Inc. (PCVX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-PCVX">PCVX stock price</a> by FreeTheAI Stocks</p>